Home›Search›Journal of Diabetes and Metabolic Disorders

Journal of Diabetes and Metabolic Disorders

Springer Science and Business Media Deutschland GmbH · Germany · Est. 2002

ISSN2251-6581eISSN2251-6581

SJR Q2✓ WOS ESCI✓ Scopus / SJR

Removed from DOAJ (2018-06-12). DOAJ's stated reason: Journal is not open access. A removal from the Directory of Open Access Journals is a quality/transparency signal — it can mean the journal became inactive or failed DOAJ's re-review criteria. This is not proof of predatory practice, but verify the journal's current status and policies before submitting. Check on DOAJ ↗

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (ESCI) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q2. Source: Clarivate Journal Citation Reports.

📊 Standing in its field

Where this journal ranks among others in the same subject area.

SJR · Scopus

Top 50% in field

Clarivate’s JCR quartile is a separate ranking and may differ

SJR Scorei

0.583

H-Indexi

SNIPi

0.714

Total Worksi

2,059

Total Citationsi

31,460

2yr Mean Citednessi

1.62

Open Impact Factor alternative

Retractions

Source: Retraction Watch

Aims & Scope

The Journal of Diabetes & Metabolic Disorders is a peer-reviewed journal publishing original clinical and translational articles and reviews in endocrinology and related areas of research. Official Journal of the Endocrinology and Metabolism Research Institute. Provides a high-quality forum for debates on relevant issues.

General Information

Country / RegionGermany

Primary LanguageEnglish

1st Year Published2002

FrequencyAnnual

StatusActive (last: 2026)

Total Publications2,059

Publisher OrgSpringer Nature

Visit Journal Website

Submission Info

Peer Review—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

6/11 · 55%

✅

Do you know the journal / publisher?

Springer Science and Business Media Deutschland GmbH

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

2251-6581 / 2251-6581

✅

Indexed in a trusted database?

WoS, Scopus, PubMed

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

✅

Primary language documented?

English

A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

1.9k

2019

213

5.6k

2020

240

3.3k

2021

235

2.2k

2022

194

1.1k

2023

167

731

2024

277

581

2025

231

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Internal MedicineQ2

Endocrinology, Diabetes and MetabolismQ3

Subject Classification

Web of Science Categories

Endocrinology & Metabolism

Scopus Categories

Endocrinology, Diabetes and MetabolismInternal Medicine

Research Topics (OpenAlex)

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Management and EducationAdipokines, Inflammation, and Metabolic DiseasesDiabetes Management and ResearchDiabetes Treatment and ManagementNatural Antidiabetic Agents StudiesDiabetes and associated disordersDiabetic Foot Ulcer Assessment and ManagementPancreatic function and diabetesHyperglycemia and glycemic control in critically ill and hospitalized patients

Frequently asked questions about Journal of Diabetes and Metabolic Disorders

Is Journal of Diabetes and Metabolic Disorders a predatory journal?

Journal of Diabetes and Metabolic Disorders was withdrawn from the Directory of Open Access Journals (DOAJ) — DOAJ's stated reason: "Journal is not open access" (2018-06-12). Withdrawal is not a predatory verdict, but it is a material editorial signal; it remains indexed in Web of Science, Scopus. Verify the journal's current status on DOAJ and its official site before submitting.

What is the impact factor of Journal of Diabetes and Metabolic Disorders?

Journal of Diabetes and Metabolic Disorders is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 1.62.

Is Journal of Diabetes and Metabolic Disorders indexed in Scopus and Web of Science?

Journal of Diabetes and Metabolic Disorders is indexed in Web of Science, Scopus.